ADAR1 Capital Management »

Research Alliance Corp Iii shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Research Alliance Corp Iii shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Research Alliance Corp Iii

Tip: Access up to 7 years of quarterly data

All positions including Research Alliance Corp Iii held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Research Alliance Corp Iii by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.0M 650k 10.70

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Zai Lab Adr (ZLAB)
Agios Pharmaceuticals (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Anteris Technologies Global (AVR)
Editas Medicine (EDIT)
Denali Therapeutics (DNLI)
Spyre Therapeutics Com New (SYRE)

View all positions for ADAR1 Capital Management

Top funds holding Research Alliance Corp Iii

Perceptive Advisors
ADAR1 Capital Management
BVF
Balyasny Asset Management
Spruce Street Capital
Trails Edge Capital Partners
TCG Crossover Management
Commodore Capital
Jupiter Topco
Braidwell
Cormorant Asset Management
Affinity Asset Advisors
Silverarc Capital Management
VR Adviser
J. Goldman & Co

View all funds holding Research Alliance Corp Iii